Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Atorvastatin in NSTE-ACS Patients Undergoing PCI
NCT01040936Phase 4Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- May 2010
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atorvastatin in non-ST elevation acute coronary syndrome (NSTE-ACS) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Major Adverse Cardiac Events at 1 year. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
non-ST elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NCT01040936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01040936.